RBP4 and neoplasm: Intriguingly, RBP4 was also reported to function as a biomarker for cardiovascular diseases risk, suggesting a potential role of metabolic dysregulation of RBP4, which could be associated with advanced glycolysis rate in the RBP4+ tumor cells.